The elevated expression of FABP4 was confirmed as a robust risk factor for the progression of CRC in a Chinese cohort [100], while an in-silico study also uncovered that FABP4 imposed conceivably poor prognosis on CRCs [25]. The gene discussed is FABP4; the disease is colorectal carcinoma.